Navigation Links
Steps Toward Stopping Autoimmune Disease: International Consortium Identifies Genes Linked to Lupus
Date:1/20/2008

hings that, at the end of your career, you can look back on and smile because you believe it will make a real difference."

SLEGEN Director John B. Harley, M.D., Ph.D., explained that the study found strong evidence of association with multiple single nucleotide polymorphisms (SNPs) in three genes: ITGAM; KIAA1542; PXK; and at SNP rs10798269, a DNA unit not found within any known gene. SNPs are chromosome locations where a single unit of DNA may vary from one person to another.

The results also showed evidence linking lupus to nine other genes. "I would have been satisfied with finding one gene. The fact that we present 13 strong candidates, supported by data that are 99% accurate is tremendous," added Harley, who heads the Arthritis & Immunology Research Program at the Oklahoma Medical Research Foundation in Oklahoma City.

Researchers studied the DNA of more than 6,700 women, including individuals with lupus, their family members and control subjects. Harley said they scanned the entire genome for more than 317,000 SNPs with the goal of identifying SNPs linked to lupus.

"SLEGEN's purpose is to do the genomics," Harley said. "The mechanism of the disease by which these genes cause lupus will be seized upon by scientists who are expert in those pathways to develop new strategies for prevention and therapy and reduce the burden of suffering this disease causes."

Langefeld said the accomplishments made in the SLEGEN research wouldn't have been possible without the support of ALR. "We simply would not have been able to do it without them."

"We are very pleased to see the findings in print and are grateful that the ALR support for SLEGEN has had such a fruitful outcome," said Joseph E. Craft, M.D., chief of rheumatology at Yale University School of Medicine and former chair of the ALR Scientific Advisory Board.

The Alliance for Lupus Research (ALR) is a national voluntary health organization based in New York City and found
'/>"/>

SOURCE Alliance for Lupus Research
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Preclinical Studies Show Potential Progress Toward Identifying Specific Tumor Types With Higher Likelihood of Demonstrating Response to Anti-Cancer Compounds Early in Clinical Development
2. Ardea Biosciences, Inc. Announces New Clinical Development Program Directed Toward the Treatment of Gout
3. Hillary Clinton Pledges Bold Approach to Stopping HIV/AIDS & Global Poverty
4. Intellect Neurosciences, Inc. to Present Data on Alzheimers Vaccine at 13th International Congress of Immunology Conference
5. Paper in International Journal of Oncology Reports Alfacells ONCONASE(R) Suppresses Intracellular Oxidative Stress
6. Ozarelix Phase 2 Data Presented at 29th Congress of the Societe Internationale dUrologie
7. Anadys Pharmaceuticals Presents Preclinical Results on ANA598, a Non-Nucleoside Inhibitor of the NS5B Polymerase, at the 14th International Symposium on Hepatitis C Virus and Related Viruses
8. International Expert Group Initiates Largest Multi-center Phase III Trial to Evaluate NeuroAid(TM) in Stroke Recovery
9. Surface Logix Presents Positive Phase 1 Repeat-Dose Trial Data on SLx-4090 at The 16th International Symposium on Drugs Affecting Lipid Metabolism
10. Preclinical Data on Lead MEK Inhibitor, RDEA119, to be Presented at the 2007 AACR-NCI-EORTC International Conference on Molecular Targets and Cancer Therapeutics
11. Tumor Growth Inhibition and Pharmacokinetic Profile of NKTR-102 (PEG-Irinotecan) in Multiple Solid Tumors To Be Presented at Upcoming AACR-NCI-EORTC International Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/4/2009)... 4 Drs. Neal Shore and E. David Crawford ... additional analysis of secondary end points of biochemical recurrence ... (monthly degarelix for injection) or monthly leuprolide in prostate ... Prostate cancer patients who received FIRMAGON 240/80 mg/month had ...
(Date:12/4/2009)... WILMINGTON, Del., Dec. 4 AstraZeneca (NYSE: ... Drug Administration (FDA) has approved once-daily SEROQUEL XR® (quetiapine ... antidepressants in adults with Major Depressive Disorder (MDD). SEROQUEL ... by the FDA to treat both major depressive disorder ...
(Date:12/3/2009)... NEW YORK, Dec. 3 Guidepoint Global, LLC , ... their Sleep Apnea Tracker, a monthly longitudinal data release that ... Sleep Apnea market. ,, The Sleep Apnea Tracker captures ... sold in the United States from 15 different equipment providers ...
Breaking Medicine Technology:Degarelix (FIRMAGON(R)) vs Leuprolide (Lupron Depot(R)) in Patients With Advanced Prostate Cancer: Further Analysis From a Phase III Pivotal Trial 2Degarelix (FIRMAGON(R)) vs Leuprolide (Lupron Depot(R)) in Patients With Advanced Prostate Cancer: Further Analysis From a Phase III Pivotal Trial 3Degarelix (FIRMAGON(R)) vs Leuprolide (Lupron Depot(R)) in Patients With Advanced Prostate Cancer: Further Analysis From a Phase III Pivotal Trial 4US FDA Approves SEROQUEL XR(R) For Add-On Treatment of Major Depressive Disorder 2US FDA Approves SEROQUEL XR(R) For Add-On Treatment of Major Depressive Disorder 3US FDA Approves SEROQUEL XR(R) For Add-On Treatment of Major Depressive Disorder 4US FDA Approves SEROQUEL XR(R) For Add-On Treatment of Major Depressive Disorder 5US FDA Approves SEROQUEL XR(R) For Add-On Treatment of Major Depressive Disorder 6US FDA Approves SEROQUEL XR(R) For Add-On Treatment of Major Depressive Disorder 7US FDA Approves SEROQUEL XR(R) For Add-On Treatment of Major Depressive Disorder 8US FDA Approves SEROQUEL XR(R) For Add-On Treatment of Major Depressive Disorder 9Leading Primary Research Firm Guidepoint Global Announces Launch of Sleep Apnea Tracker 2U of A and leading German researchers team up to build oil sands sustainability 10182 1U of A and leading German researchers team up to build oil sands sustainability 10182 2Study in Spain and Romania confirms radon as second leading cause of lung cancer 10179 1Study in Spain and Romania confirms radon as second leading cause of lung cancer 10179 2Study in Spain and Romania confirms radon as second leading cause of lung cancer 10179 3ShowerBuddy Affordable Accessible Bathing 5101 1ShowerBuddy Affordable Accessible Bathing 5101 2
... Opening celebrated with inaugural Symposium on Biofilms, ... 29 ,BASF today announced the official launch ... University. The Advanced Research Initiative at,Harvard University ... specifically to drive new frontiers of scientific,discovery. ...
... April 29 InfraReDx, Inc. announced,today that ... U.S. Food and Drug,Administration (FDA) to market ... device uses near-infrared spectroscopy to,identify lipid core ... arteries,in patients already undergoing cardiac catheterization. Such ...
Other Medicine Technology:BASF Officially Launches the Collaborative Advanced Research Initiative at Harvard University 2BASF Officially Launches the Collaborative Advanced Research Initiative at Harvard University 3FDA Grants Market Clearance for the LipiScan(TM) Coronary Imaging System Developed by InfraReDx, Inc. - A Novel Spectroscopy System for the Identification of Lipid Core Containing Plaques of Interest in the Coronary Arteries 2FDA Grants Market Clearance for the LipiScan(TM) Coronary Imaging System Developed by InfraReDx, Inc. - A Novel Spectroscopy System for the Identification of Lipid Core Containing Plaques of Interest in the Coronary Arteries 3FDA Grants Market Clearance for the LipiScan(TM) Coronary Imaging System Developed by InfraReDx, Inc. - A Novel Spectroscopy System for the Identification of Lipid Core Containing Plaques of Interest in the Coronary Arteries 4
(Date:12/5/2009)... Leukemia and myeloproliferative disorders are serious and often ... 51st Annual Meeting of the American Society of ... diagnostic methods for patients suffering from acute promyelocytic ... and myelofibrosis that are based on a better ...
(Date:12/5/2009)... debunks the ,something,s wrong with being single, myth , , SATURDAY, ... who pass their 40th birthday without ever tying the knot, ... woes than married folks. And, um, isn,t there something wrong ... fast. , A new study looking at psychological measures shows ...
(Date:12/5/2009)... new international private medical insurance plan which follows the acclaimed modular ... flexibility to add or remove a wide range of options to ... their benefits to complement those already offered in their country of ... ...
(Date:12/5/2009)... are popping up in the most unusual places, and to do everything ... ... (PRWEB) December 5, 2009 -- Who would have thought that your wine, ... Fort Worth, Texas has announced a new line of turbines, for industry ...
(Date:12/4/2009)... Dec. 4 Care Investment Trust Inc. (NYSE: ... Board of Directors has declared a dividend of $0.17 per share ... 2009 to common shareholders of record on December 14, 2009. ... Investment Trust Inc. is a real estate investment and finance company ...
Breaking Medicine News(10 mins):Health News:Advances in Genetic Understanding and Treatment Protocols Lead to Significant Progress in Leukemia and Myeloproliferative Disorders 2Health News:Advances in Genetic Understanding and Treatment Protocols Lead to Significant Progress in Leukemia and Myeloproliferative Disorders 3Health News:Advances in Genetic Understanding and Treatment Protocols Lead to Significant Progress in Leukemia and Myeloproliferative Disorders 4Health News:Advances in Genetic Understanding and Treatment Protocols Lead to Significant Progress in Leukemia and Myeloproliferative Disorders 5Health News:Advances in Genetic Understanding and Treatment Protocols Lead to Significant Progress in Leukemia and Myeloproliferative Disorders 6Health News:Advances in Genetic Understanding and Treatment Protocols Lead to Significant Progress in Leukemia and Myeloproliferative Disorders 7Health News:Advances in Genetic Understanding and Treatment Protocols Lead to Significant Progress in Leukemia and Myeloproliferative Disorders 8Health News:Advances in Genetic Understanding and Treatment Protocols Lead to Significant Progress in Leukemia and Myeloproliferative Disorders 9Health News:Never Married, Over 40, Well-Adjusted 2Health News:Never Married, Over 40, Well-Adjusted 3Health News:AVIVA's Private Health Insurance Products Solutions Go International 2Health News:Distributor Announces New Applications for Wind Turbines 2Health News:Distributor Announces New Applications for Wind Turbines 3Health News:Care Investment Trust Inc. Declares Quarterly Dividend of $0.17 Per Share 2
... (OTC Bulletin Board: LFVN) today announced the appointment ... of the company,effective January 14, 2008. LifeVantage Corporation ... dietary supplement that,increases the body,s natural antioxidant protection ... Chairman of the Board of LifeVantage said, "David,Brown ...
... for the first time that the brain processes aggression ... drugs - offering insights into our propensity to fight ... football. , The research will be published online the ... Aggression occurs among virtually all vertebrates and is necessary ...
... everything from spinach to meat to children,s snacks , , MONDAY, Jan. ... and a half, the list of tainted foods has become as ... is stark: , , An E. coli bacteria outbreak in bagged ... and sickened more than 200 others in 26 states and Canada. ...
... oldest members of the largest,generation in U.S. history began ... 79 million baby boomers to be eligible to retire ... as 2.8 million,62-year-olds ponder retirement, in a series called ... will be reported in the newspaper and online at,USATODAY.com ...
... Study finds only those that regulate LDL levels influence ... -- Seven new cholesterol-regulating genes, some of which influence the ... international study of almost 20,000 people in three countries. ... will be the targets for future drugs," said the ...
... Promise to Deliver ... 12 Hala Moddelmog, president and CEO of,Susan G. Komen ... end breast,cancer forever, today was recognized for her leadership in ... a ,High Heels in High,Places, award. The Trumpet Awards Foundation, ...
Other Medicine News:Health News:LifeVantage Corporation Appoints Industry Veteran David Brown as President & CEO 2Health News:LifeVantage Corporation Appoints Industry Veteran David Brown as President & CEO 3Health News:LifeVantage Corporation Appoints Industry Veteran David Brown as President & CEO 4Health News:Aggression as rewarding as sex, food and drugs 2Health News:U.S. Food Safety: A Grocery List of Tainted Products 2Health News:USA TODAY to Report Special Series "Turning 62: The Retirement Boom Begins" 2Health News:Seven New Cholesterol Genes Discovered 2Health News:Seven New Cholesterol Genes Discovered 3Health News:Susan G. Komen for the Cure's CEO Hala Moddelmog Earns 'High Heels in High Places' Recognition at 2008 Trumpet Awards 2Health News:Susan G. Komen for the Cure's CEO Hala Moddelmog Earns 'High Heels in High Places' Recognition at 2008 Trumpet Awards 3
ISI Micro Brushes are available in a variety of French diameters. Made with stainless steel handles and nylon bristles, the ISI Micro Brushes will last through countless cleanings....
... instrument cleaning brushes in a ... composition. The long, thin brushes ... tubing. The smallest brushes are ... brass and stainless steel brushes ...
... The ISI Brush Nest is the wall organizer ... in a variety of sizes and diameters. Made ... shelf, the ISI Brush Nest is the ultimate ... 18 specialized brushes in a variety of lengths, ...
... stands for Stainless Steel Kleener. SSK-80 is ... and stain remover for ultra-sonic cleaners. , ... of your instruments by removing and inhibiting ... pivot points, box joints and moving instrument ...
Medicine Products: